Gernot Polier Selected Research

T-Cell Leukemia (Leukemia, T Cell)

2/2015

Targeting CDK9 by wogonin and related natural flavones potentiates the anti-cancer efficacy of the Bcl-2 family inhibitor ABT-263.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gernot Polier Research Topics

Disease

3	Neoplasms (Cancer) 02/2015 - 02/2011
1	T-Cell Leukemia (Leukemia, T Cell) 02/2015
1	Lymphoid Leukemia 02/2015
1	Lymphoma (Lymphomas) 02/2015
1	Thrombocytopenia (Thrombopenia) 02/2015
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Colonic Neoplasms (Colon Cancer) 01/2012
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Melanoma (Melanoma, Malignant) 01/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2012
1	Mycosis Fungoides 02/2011

Drug/Important Bio-Agent (IBA)

2	wogoninIBA 02/2015 - 01/2012
2	FlavonesIBA 02/2015 - 01/2012
2	ApigeninIBA 02/2015 - 01/2012
2	chrysinIBA 02/2015 - 01/2012
1	LuteolinIBA 02/2015
1	baicaleinIBA 02/2015
1	Apoptosis Regulatory ProteinsIBA 02/2015
1	navitoclaxIBA 02/2015
1	venetoclaxIBA 02/2015
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2012
1	Antineoplastic Agents (Antineoplastics)IBA 01/2012
1	LigandsIBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2012
1	Amino Acids FDA Link 02/2011
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2011

Therapy/Procedure

1	Therapeutics 02/2015